Enlight Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 7 Year, 18 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 276.38%
(FY 2020)
- Profit -367.95%
(FY 2020)
- Ebitda -101.55%
(FY 2020)
- Net Worth -471.54%
(FY 2020)
- Total Assets 10.31%
(FY 2020)
About Enlight Life Science
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anupama Amarnath and Mysore Amarnath serve as directors at the Company.
- CIN/LLPIN
U15100KA2017PTC108442
- Company No.
108442
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Enlight Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mysore Amarnath  | Whole-Time Director | 05-Dec-2017 | Current |
| Anupama Amarnath | Whole-Time Director | 05-Dec-2017 | Current |
Financial Performance of Enlight Life Science.
Enlight Life Science Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 276.38% increase. The company also saw a substantial fall in profitability, with a 367.95% decrease in profit. The company's net worth observed a substantial decline by a decrease of 471.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enlight Life Science?
Unlock access to Enlight Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aashraya Confectionery India Private LimitedActive 12 years 11 monthsAnupama Amarnath and Mysore Amarnath are mutual person
Heptacoin Block Chain Technologies Private LimitedActive 3 years 1 monthAnupama Amarnath and Mysore Amarnath are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Enlight Life Science?
Unlock and access historical data on people associated with Enlight Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enlight Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enlight Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
